Annexin V staining revealed that the number of surviving CD44‐positive GBM‐MG1 and GBM‐MG2 cells was significantly higher than that of CD44‐negative GBM‐MG1 and GBM‐MG2 cells (Figure 3I). This evidence concerns the gene CD44 and glioblastoma.